Expression of extracellular matrix molecules in control and diabetic rats CTGF and CYR61 are known modifiers of the extracellular matrix.
Only in the very late stages of OA does synthesis of matrix molecules drop below control levels.
New developments, such as the biomimetic approach which combines the use of scaffolds with extracellular matrix molecules, may improve the control of cell proliferation, survival, migration, differentiation and engraftment in vivo.
It is likely that growth factors other than TGFβ and/or matrix molecules will be important in the control of epithelial morphology, and should be explored in the future.
Alternatively, in light of emerging evidence highlighting a role for the 3′ UTR of matrix molecule mRNAs in controlling miRNA function (Jeyapalan and Yang, 2012; Lee et al., 2009), noncoding regions of the tenascin-C gene may drive miRNA biogenesis.
In a promising study, a chondrocyte-fibrin suspension injected into critical-sized cartilage defects in vivo, resulted in the successful deposition of cartilage-specific extracellular matrix molecules and improved healing as compared to untreated control defects [ 9].
The turnover rates of matrix molecules and the proteases that degrade them are under control of an extensive network of cytokines, growth factors, proteases, lipid mediators, and mechanical forces.
We have also investigated matrix metalloproteinases (MMP) and their inhibitors, TIMP, in patients with CDK, because these molecules control the degradation of the corneal epithelium and stroma.
The hematopoietic microenvironment controls the formation of blood cells through the release of cytokines and extracellular matrix molecules.
The adhesive proteins of the extracellular matrix bind matrix molecules to one another and to cell surfaces.
